Publication | Open Access
Phase 1 Study of an Intravitreal Axitinib Hydrogel-based Implant for the Treatment of Neovascular Age-Related Macular Degeneration (nAMD)
12
Citations
0
References
2021
Year
No additional data available for this publication yet. Check back later!